Login / Signup

[Three-component tear substitute as preoperative support in glaucoma surgery].

N V MakashovaA E VasillyevaO Yu Kolosova
Published in: Vestnik oftalmologii (2024)
The use of tear substitute Stillavit in preparation for anti-glaucoma surgery reduces the chances of IOP elevation in the early postoperative period by more than 10 times, which may indicate a reduction in the rate of FB scarring due to the beneficial effect of the drug's components on the precorneal tear film.
Keyphrases
  • minimally invasive
  • coronary artery bypass
  • patients undergoing
  • surgical site infection
  • gold nanoparticles
  • molecularly imprinted
  • cataract surgery
  • acute coronary syndrome
  • adverse drug